Prosaposin – A plausible biomarker in head and neck squamous cell carcinoma
Authors:
- Avradeep DattaADAvradeep Datta
- Rajandeep KaurRKRajandeep Kaur
- Anshika ChauhanACAnshika Chauhan
- Geeta Singh BooraGBGeeta Singh Boora
- Himanshu GargHGHimanshu Garg
- Debajyoti ChatterjeeDCDebajyoti Chatterjee
- Jaimanti BakshiJBJaimanti Bakshi
- Sushmita GhoshalSGSushmita Ghoshal
- Arnab PalArnab Pal
Open Access
- 8 February 2024
- journal article
- research article
- Published by Elsevier in Oral Oncology Reports
- Vol. 9
Abstract
No abstract availableKeywords
Funding Information
- Postgraduate Institute of Medical Education and Research, Chandigarh (71/2-Edu/16/4844-45)
- Council of Scientific and Industrial Research, India (09/141(0209)/2019)
- Council of Scientific and Industrial Research, India (09/141(0210)/2019)
This publication has 25 references indexed in Scilit:
- Alcohol and Tobacco Increases Risk of High Risk HPV Infection in Head and Neck Cancer Patients: Study from North-East Region of IndiaPLOS ONE, 2015
- Identification of prosaposin and transgelin as potential biomarkers for gallbladder cancer using quantitative proteomicsBiochemical and Biophysical Research Communications, 2014
- Head and Neck Cancer Burden in IndiaInternational Journal of Head and Neck Surgery, 2013
- Quantitative tissue proteomics of esophageal squamous cell carcinoma for novel biomarker discoveryCancer Biology & Therapy, 2011
- Serum prosaposin levels are increased in patients with advanced prostate cancerThe Prostate, 2011
- Biospecimen Reporting for Improved Study Quality (BRISQ)Journal of Proteome Research, 2011
- Identification of proteins secreted by head and neck cancer cell lines using LC‐MS/MS: Strategy for discovery of candidate serological biomarkersProteomics, 2011
- Prevalence of human papillomavirus types in cervical and oral cancers in central IndiaVaccine, 2009
- Biomarker Discovery from Pancreatic Cancer Secretome Using a Differential Proteomic ApproachMolecular & Cellular Proteomics, 2006
- REporting recommendations for tumour MARKer prognostic studies (REMARK)British Journal of Cancer, 2005